A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery

References

• M.N.H. Fateme Haghiralsadat, Ghasem Amoabediny, Behrouz Zandieh-doulabi, Posthuma de Boer Jantine, Treatment of osteosarcoma metastases: Codelivery of siRNA and small molecule anticancer drugs based Nano-biotechnology: a review, Biotechnol. Adv. (2016).
   Google Scholar
• Gumulec J, Fojtu M, Raudenska M, et al. Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages. Int J Mol Sci. 2014;15:22960–22977.
   PubMed Web of Science ®Google Scholar
• MajidiZeinali Sehrig S, Samiei F, Milani M, etet al. Magnetic nanoparticles: applications in gene delivery and gene therapy, Artif. Cells Nanomedicine Biotechnol. 2016;44:1186–1193.
   PubMed Web of Science ®Google Scholar
• Singh B, Garg T, Goyal AK, et al. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 2016;44:216–225.
   PubMed Web of Science ®Google Scholar
• Xiong XY, Tam KC, Gan LH. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly (lactic acid) nanoparticles. J Control Release. 2005;103:73–82.
   PubMed Web of Science ®Google Scholar
• Mourtas S, Fotopoulou S, Duraj S, et al. Liposomal drugs dispersed in hydrogels: effect of liposome, drug and gel properties on drug release kinetics. Colloids Surf Biointerfaces. 2007;55:212–221.
   PubMed Web of Science ®Google Scholar
• Sanson C, Schatz C, Le Meins J-F, et al. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J Control Release. 2010;147:428–435.
   PubMed Web of Science ®Google Scholar
• Fateme Haghiralsadat B, Amoabediny ZG, Sheikhha MH, et al. A novel approach on drug delivery: investigation of new nano-formulation of liposomal doxorubicin and biological evaluation of entrapped doxorubicin on various osteosarcomas cell lines. Cell J. 2017 (in press). http://celljournal.org/journal/article/abstract/4502
   PubMed Web of Science ®Google Scholar
• Kim B-K, Seu Y-B, Bae Y-U, et al. Efficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkages. IJMS. 2014;15:7293–7312.
   Google Scholar
• Chen Y, Bathula SR, Li J, et al. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem. 2010;285:22639–22650. doi:10.1074/jbc.M110.125906.
   PubMed Web of Science ®Google Scholar
• Boer JPD. Towards targeted treatment for osteosarcoma. Amsterdam, Netherlands: VU University Medical Center; 2014.
   Google Scholar
• HaghiralsadatAmoabediny FG, Sheikhha M, Zandieh-doulabi H, et al. New liposomal doxorubicin nanoformulation for osteosarcoma: drug release kinetic study based on thermo and pH sensitivity. Chem Biol Drug Des. 2017. [Epub ahead of print].doi: 10.1111/cbdd.12953
   Web of Science ®Google Scholar
• Madden TD, Harrigan PR, Tai LCL, et al. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids. 1990;53:37–46.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
   Web of Science ®Google Scholar
• MJ. Procopio An experimental analysis of classifier ensembles for learning drifting concepts over time in autonomous outdoor robot navigation, ProQuest, Boulder, 2007.
   Google Scholar
• B. Vidakovic Statistics for bioengineering sciences: with MATLAB and WinBUGS Support, 2nd ed. Springer Science & Business Media, 2011.
   Google Scholar
• De Boer JP, van Egmond PW, Helder MN, et al. Targeting JNK-interacting protein 1 (JIP1) sensitises osteosarcoma to doxorubicin. Oncotarget. 2012;3:1169–1181.
   PubMed Web of Science ®Google Scholar
• Kim J-Y, Kim J-K, Park J-S, et al. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials. 2009;30:5751–5756.
   PubMed Web of Science ®Google Scholar
• Li Y-P, Pei Y-Y, Zhang X-Y, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71:203–211.
   PubMed Web of Science ®Google Scholar
• Xiao W, Chen X, Yang L, et al. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Int J Pharm. 2010;393:120–127.
   Web of Science ®Google Scholar
• Posthumadeboer J, Piersma SR, Pham TV, et al. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. Br J Cancer. 2013;109:2142–2154.
   PubMed Web of Science ®Google Scholar
• Nie Y, Ji L, Ding H, et al. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics. 2012;2:1092–1103.
   PubMed Web of Science ®Google Scholar
• R, Peck J. Devore Statistics: The Exploration & Analysis of Data, 7th ed. Cengage Learning: Boston, 2011.
   Google Scholar